Watchmaker Genomics has expanded its molecular diagnostics portfolio with the launch of Stellar RT qPCR and qPCR Kits, designed for assay developers working across PCR and isothermal modalities. The kits incorporate the company’s engineered StellarTaq™ DNA Polymerase and StellarScript® HT+ Reverse Transcriptase to support rapid cycling and amplification from crude or minimally processed samples. They are intended for use in applications requiring fast turnaround and inhibitor tolerant performance, including point of care and field deployable testing. The kits complement Watchmaker’s recombinase polymerase amplification (RPA) enzyme suite.